|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1501 M Street, NW |
Address2 | Suite 300 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Park Ridge |
State | IL |
Zip Code | 60068-2573 |
Country | USA |
|
5. Senate ID# 3388-12
|
||||||||
|
6. House ID# 315460000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Ronald Szabat, JD, LLM, Executive Vice President and General Counsel |
Date | 10/14/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2204, Medicare Access to Rural Anesthesiology Act: Rural Pass Through; S.1157, Craig Thomas Rural Hospital and Provider
Equity Act of 2009; S.1776, Medicare Physician Fairness Act of 2009; H.R. 3961, Medicare Physician Payment Reform Act of
2009; Johnson Amendment, An amendment to H.R. 3200 to set Medicare payment rates for anesthesia services at a rate not less than the average paid by exchange participant health benefit plans.
H.R. 4371, To amend the Social Security Act to continue using 2009 relative value units for certain cardiology services.
Part B Medicare Physician's Fee Schedule: Implementation of Medicare Anesthesiology Teaching Funding Restoration Act
H.R. 4851, The Continuing Extension Act of 2010
H.R. 4213, Tax Extenders Act of 2009
H.R. 4691, The Temporary Extension Act of 2010
H.J. Res. 45 Statutory Pay-As-You-Go Act of 2010
H.R. 4872, The Health Care and Education Affordability and Reconciliation Act of 2010
2010 Medicare Physician Fee Schedule proposed and final rules
Medicare Reform, Payment Issues: Physician Quality Reporting Initiative, Medicare Sustainable Growth Rate Physician Payment Update
Scope of Practice
Bundled payments
CMS ACE Demonstration
CMS Interpretive Guidelines
CMS IPPS Medicare Payment
CMS Physician Resource Use Reports
CMS ICD-10
CMS Medicare Physician Practice Expense Relative Value Units
CMS Hospital Outpatient Payment Proposed Rule
CMS Hospital Acquired Conditions
CMS Value-Based purchasing
CMS Recovery Audit Contractors Program
CMS Practicing Physicians' Advisory Council Nominations
Medicaid Expansion: Provider payment levels
Medicare Expansion, Ages 55-64
Independent Payment Advisory Board (IPAB)
Balance billing
MedPAC nominations
CMS Handoffs
Anesthesia Information Management System (AIMS)
Accountable Care Organizations
Misvalued codes
Historical Medicare payment undervaluation for anesthesiology services (33% problem)
Medical loss ratios
Nevada Medicaid anesthesia payment rates
Anesthesia Conversion Factor
Public Plan - Negotiated Provider Payment Rates
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald |
Szabat |
|
|
|
Manuel |
Bonilla |
|
|
|
Harvey |
Amoe |
|
|
|
Sharon |
Merrick |
|
|
|
Jason |
Byrd |
|
|
|
Michelle |
Mathy |
|
|
|
Christopher |
Meekins |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Healthcare Reform: S.391, H.R. 1321 Healthy Americans Act; H.R. 193 American Healthcare Act; H.R. 3200, America's Affordable Health Choices Act; America's Healthy Futures Act of 2009; H.R. 3962, Affordable Healthcare for America Act; H.R. 3590 Patient Protection and Affordable Care Act, Pub. Law No: 111-148
H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act
H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010
H.R. 5808, To amend the Patient Protection and Affordable Care Act to establish a public health insurance option.
Nondiscrimination language regarding paraprofessionals
H.R. 5295, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation
H.R. 756, National Pain Care Policy Act, S.660, National Pain Care Policy Act
DEA E-Prescribing
DEA Propofol
Comparative Effectiveness Research
Hospital Acquired Infections
HITECH Implemenation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use
Data Registry Funding
HHS/OIG Anesthesia Practice Arrangements, Company Model
FDA Risk Evaluation and Mitigation Strategies
Physician Antitrust Relief
Physician Workforce Issues
Medical Liability Reform
FDA Safe Use Initiative
FDA Operating Room Fires
FDA ACTION Initiative
FDA Propofol Shortage
Compliance with Senate Finance Committee request
FDA Scheduling of Propofol
FDA Sentinel
Non-Anesthesia Provider Use of Propofol
Prescription Drug User Fee Act
Deep sedation
NASPER Funding
Required Physician Supervision of Nurse Anesthetists, Nurse error rates
State Exchanges pursuant to PPACA
Patient Safety Initiatives
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Office of Management & Budget (OMB), Executive Office of the President (EOP), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald |
Szabat |
|
|
|
Manuel |
Bonilla |
|
|
|
Harvey |
Amoe |
|
|
|
Sharon |
Merrick |
|
|
|
Jason |
Byrd |
|
|
|
Michelle |
Mathy |
|
|
|
Christopher |
Meekins |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
No lobbying activity in this issue area in Q3 2010.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald |
Szabat |
|
|
|
Manuel |
Bonilla |
|
|
|
Harvey |
Amoe |
|
|
|
Sharon |
Merrick |
|
|
|
Jason |
Byrd |
|
|
|
Michelle |
Mathy |
|
|
|
Christopher |
Meekins |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |